552c7ae14ClaimPope Leo XIV was discharged from Rome's Gemelli Polyclinic on Saturday afternoon, October 17, 2026, four days after undergoing lung cancer surgeryAgreeDisagree
552c7ae14ClaimTissue examination following Pope Leo XIV's October 13, 2026 surgery confirmed a diagnosis of lung adenocarcinoma, the most common form of lung cancerAgreeDisagree
552c7ae14ClaimThe Vatican cleared Pope Leo XIV's public schedule through October 20, 2026, while maintaining preparations for his November 6-17 trip to Uruguay, Argentina, and PeruAgreeDisagree
552c7ae14ClaimPope Leo XIV is scheduled to lead the Angelus prayer from the window of the papal apartment overlooking St. Peter's Square on Sunday, October 18, 2026AgreeDisagree
552c7ae14ClaimOn Friday, October 16, 2026, Pope Leo XIV telephoned Russian President Vladimir Putin to urge dialogue, peace, and a ceasefire in Ukraine, specifically requesting a humanitarian ceasefire in the Russian-occupied Ukrainian city of OleshkyAgreeDisagree
552c7ae14ClaimOn Friday, October 16, 2026, Pope Leo XIV celebrated Mass in his hospital suite and walked without physical assistance, as shown in photographs released by the VaticanAgreeDisagree
552c7ae14ClaimPope Leo XIV publicly announced his localized lung nodule diagnosis on Sunday, October 11, 2026, during an address in St. Peter's Square prior to his scheduled surgeryAgreeDisagree
552c7ae14ClaimOn Tuesday, October 13, 2026, surgeons at Gemelli Polyclinic performed a 90-minute video-assisted operation that removed a cancerous nodule and the lower lobe of Pope Leo XIV's right lungAgreeDisagree
552c7ae14ClaimPersonal physician Dr. Luigi Carbone and chief thoracic surgeon Professor Stefano Margaritora declared Pope Leo XIV fit for discharge following morning blood tests and chest X-rays on October 17, 2026AgreeDisagree
552c7ae14ClaimVatican spokesperson Matteo Bruni stated that Pope Leo XIV's estimated post-operative recovery time will be approximately one weekAgreeDisagree
552c7ae14ClaimMedical experts not involved in Pope Leo XIV's care stated that using surgery as the primary intervention for his October 13, 2026 operation indicates his lung cancer was caught at an early stageAgreeDisagree
552c7ae14ClaimPope Leo XIV and Russian President Vladimir Putin previously held a phone call in June 2025 prior to their October 16, 2026 conversationAgreeDisagree
552c7ae14ClaimSatralizumab is a humanized monoclonal antibody designed to bind to soluble and membrane-bound interleukin-6 receptors, inhibiting interleukin-6-mediated inflammatory signalingAgreeDisagree
552c7ae14ClaimThyroid eye disease is an inflammatory autoimmune condition affecting an estimated 16 women and 3 men per 100,000 population, commonly occurring in people with hyperthyroidismAgreeDisagree
552c7ae14ClaimSatralizumab is the first and only at-home subcutaneous treatment cleared by the FDA for adults with thyroid eye diseaseAgreeDisagree
552c7ae14ClaimPrior to satralizumab's approval, the FDA approved two intravenous thyroid eye disease treatments targeting the insulin-like growth factor 1 receptor: teprotumumab in 2020 and veligrotug in June 2026AgreeDisagree
552c7ae14ClaimSatralizumab was initially approved by the FDA in 2020 for neuromyelitis optica spectrum disorder, a rare neuroinflammatory conditionAgreeDisagree
552c7ae14ClaimSatralizumab can be self-administered subcutaneously by a patient or caregiver following initial training from a healthcare providerAgreeDisagree